This inventor holds 1 USPTO granted patent. Top assignee: Development Center for Biotechnology. Active years: 2002.
Company Filing History:
Years Active: 2002
Title: Hwa-Yi Chen: Innovator in Biochemistry
Introduction
Hwa-Yi Chen is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of biochemistry, particularly in the development of enzymes that facilitate the production of important pharmaceutical compounds. His work has implications for the synthesis of antibiotics and other vital substances.
Latest Patents
Hwa-Yi Chen holds a patent for a mutant D-amino acid aminotransferase, which is designed for simultaneously producing glutaryl-7-aminocephalosporanic acid and D-amino acid. The invention relates to the substitution of the glutamate residue at position 13 of the wild type D-amino acid aminotransferase with hydrophobic amino acids. This mutant enzyme can be utilized in the production of D-amino acid and the conversion of glutaryl-7-aminocephalosporanic acid from cephalosporin C. The patent also includes a replica-paper staining method for screening cells that express high DAT activity. Hwa-Yi Chen has 1 patent to his name.
Career Highlights
Hwa-Yi Chen is associated with the Development Center for Biotechnology, where he has been involved in various research projects aimed at enhancing biotechnological applications. His expertise in enzyme engineering has positioned him as a key figure in the development of innovative solutions in the pharmaceutical industry.
Collaborations
Hwa-Yi Chen has collaborated with notable colleagues such as Edward Yi Chang and Hsin-Hua Chou. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in biochemistry.
Conclusion
Hwa-Yi Chen's contributions to the field of biochemistry through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence the development of important pharmaceutical compounds.